262 related articles for article (PubMed ID: 20728280)
1. Edaravone: a new therapeutic approach for the treatment of acute stroke.
Kikuchi K; Kawahara K; Miyagi N; Uchikado H; Kuramoto T; Morimoto Y; Tancharoen S; Miura N; Takenouchi K; Oyama Y; Shrestha B; Matsuda F; Yoshida Y; Arimura S; Mera K; Tada K; Yoshinaga N; Maenosono R; Ohno Y; Hashiguchi T; Maruyama I; Shigemori M
Med Hypotheses; 2010 Dec; 75(6):583-5. PubMed ID: 20728280
[TBL] [Abstract][Full Text] [Related]
2. The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator.
Lapchak PA; Zivin JA
Exp Neurol; 2009 Jan; 215(1):95-100. PubMed ID: 18851964
[TBL] [Abstract][Full Text] [Related]
3. Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4.
Kikuchi K; Tancharoen S; Matsuda F; Biswas KK; Ito T; Morimoto Y; Oyama Y; Takenouchi K; Miura N; Arimura N; Nawa Y; Meng X; Shrestha B; Arimura S; Iwata M; Mera K; Sameshima H; Ohno Y; Maenosono R; Tajima Y; Uchikado H; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I; Kawahara K
Biochem Biophys Res Commun; 2009 Dec; 390(4):1121-5. PubMed ID: 19737535
[TBL] [Abstract][Full Text] [Related]
4. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
Ueno Y; Zhang N; Miyamoto N; Tanaka R; Hattori N; Urabe T
Neuroscience; 2009 Aug; 162(2):317-27. PubMed ID: 19409967
[TBL] [Abstract][Full Text] [Related]
5. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
Yamaguchi T; Awano H; Matsuda H; Tanahashi N;
J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):756-765. PubMed ID: 27887792
[TBL] [Abstract][Full Text] [Related]
6. Edaravone (radical scavenger) versus sodium ozagrel (antiplatelet agent) in acute noncardioembolic ischemic stroke (EDO trial).
Shinohara Y; Saito I; Kobayashi S; Uchiyama S
Cerebrovasc Dis; 2009; 27(5):485-92. PubMed ID: 19321945
[TBL] [Abstract][Full Text] [Related]
7. Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients--a preliminary study.
Kimura K; Aoki J; Sakamoto Y; Kobayashi K; Sakai K; Inoue T; Iguchi Y; Shibazaki K
J Neurol Sci; 2012 Feb; 313(1-2):132-6. PubMed ID: 21967833
[TBL] [Abstract][Full Text] [Related]
8. Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.
Wada T; Yasunaga H; Inokuchi R; Horiguchi H; Fushimi K; Matsubara T; Nakajima S; Yahagi N
J Neurol Sci; 2014 Oct; 345(1-2):106-11. PubMed ID: 25085762
[TBL] [Abstract][Full Text] [Related]
9. Stroke in a child safely treated with intravenous tissue plasminogen activator and edaravone, a free radical scavenger.
Baba H; Sugimori H; Nanishi E; Nagata H; Lee S; Kuwashiro T; Hashizume M
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):903.e5-8. PubMed ID: 21421331
[TBL] [Abstract][Full Text] [Related]
10. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion.
Toyoda K; Fujii K; Kamouchi M; Nakane H; Arihiro S; Okada Y; Ibayashi S; Iida M
J Neurol Sci; 2004 Jun; 221(1-2):11-7. PubMed ID: 15178207
[TBL] [Abstract][Full Text] [Related]
11. Effect of edaravone on the estimated glomerular filtration rate in patients with acute ischemic stroke and chronic kidney disease.
Tsukamoto Y; Takizawa S; Takahashi W; Mase H; Miyachi H; Miyata T; Takagi S
J Stroke Cerebrovasc Dis; 2011; 20(2):111-6. PubMed ID: 20580255
[TBL] [Abstract][Full Text] [Related]
12. The novel antioxidant edaravone: from bench to bedside.
Watanabe T; Tahara M; Todo S
Cardiovasc Ther; 2008; 26(2):101-14. PubMed ID: 18485133
[TBL] [Abstract][Full Text] [Related]
13. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
Kikuchi K; Kawahara K; Tancharoen S; Matsuda F; Morimoto Y; Ito T; Biswas KK; Takenouchi K; Miura N; Oyama Y; Nawa Y; Arimura N; Iwata M; Tajima Y; Kuramoto T; Nakayama K; Shigemori M; Yoshida Y; Hashiguchi T; Maruyama I
J Pharmacol Exp Ther; 2009 Jun; 329(3):865-74. PubMed ID: 19293391
[TBL] [Abstract][Full Text] [Related]
14. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
Isahaya K; Yamada K; Yamatoku M; Sakurai K; Takaishi S; Kato B; Hirayama T; Hasegawa Y
J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):102-7. PubMed ID: 21215657
[TBL] [Abstract][Full Text] [Related]
15. Edaravone - citicoline comparative study in acute ischemic stroke (ECCS-AIS).
Mitta M; Goel D; Bansal KK; Puri P
J Assoc Physicians India; 2012 Nov; 60():36-8. PubMed ID: 23767201
[TBL] [Abstract][Full Text] [Related]
16. A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?
Lapchak PA
Expert Opin Pharmacother; 2010 Jul; 11(10):1753-63. PubMed ID: 20491547
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of extravasation of tissue plasminogen activator by the free radical scavenger, edaravone: evaluation in a rat thromboembolic stroke model.
Kano T; Harada T; Katayama Y
Neurol Res; 2005 Jul; 27(5):499-502. PubMed ID: 15978175
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury.
Ohta M; Higashi Y; Yawata T; Kitahara M; Nobumoto A; Ishida E; Tsuda M; Fujimoto Y; Shimizu K
Brain Res; 2013 Jan; 1490():184-92. PubMed ID: 22982593
[TBL] [Abstract][Full Text] [Related]
19. New modalities for the treatment of acute cardioembolic stroke.
Uchiyama S
Intern Med; 2006; 45(8):493-4. PubMed ID: 16702738
[No Abstract] [Full Text] [Related]
20. Edaravone for acute stroke: Meta-analyses of data from randomized controlled trials.
Yang J; Cui X; Li J; Zhang C; Zhang J; Liu M
Dev Neurorehabil; 2015; 18(5):330-5. PubMed ID: 24088023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]